Simultaneously, activated autophagy and ferroptosis in rats with HF were markedly inhibited by either TLR4 or NOX4 knockdown, suggesting that TLR4-NOX4 is a potential therapeutic target for HF through the inhibition of autophagy- and ferroptosis-mediated cell death (Chen et al. 2019). This evidence concerns the gene NOX4 and hydrops fetalis.